Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer.
Authors: File DM; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Pascual T; Hospital Universitario, 12 de Octubre, Madrid, Spain.; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA., Deal AM; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA., Wheless A; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA., Perou CM; Department of Genetics, Chapel Hill, NC, USA., Claire Dees E; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA., Carey LA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Lisa_Carey@med.unc.edu.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Nov; Vol. 196 (1), pp. 153-162. Date of Electronic Publication: 2022 Aug 25.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-7217
DOI:10.1007/s10549-022-06700-6